Does OCTREOTIDE Cause Benign prostatic hyperplasia? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Benign prostatic hyperplasia have been filed in association with OCTREOTIDE (Octreotide Acetate). This represents 0.1% of all adverse event reports for OCTREOTIDE.
18
Reports of Benign prostatic hyperplasia with OCTREOTIDE
0.1%
of all OCTREOTIDE reports
1
Deaths
11
Hospitalizations
How Dangerous Is Benign prostatic hyperplasia From OCTREOTIDE?
Of the 18 reports, 1 (5.6%) resulted in death, 11 (61.1%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Benign prostatic hyperplasia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCTREOTIDE. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does OCTREOTIDE Cause?
Death (3,801)
Diarrhoea (3,621)
Fatigue (2,933)
Blood pressure increased (2,799)
Needle issue (2,740)
Malaise (2,737)
Pain (2,366)
Blood pressure systolic increased (2,340)
Malignant neoplasm progression (2,306)
Nausea (2,294)
What Other Drugs Cause Benign prostatic hyperplasia?
TADALAFIL (596)
TAMSULOSIN (304)
FINASTERIDE (266)
PANTOPRAZOLE (261)
PREDNISONE (257)
ALBUTEROL (254)
ASPIRIN (243)
TIOTROPIUM (235)
RAMIPRIL (193)
AMLODIPINE (179)
Which OCTREOTIDE Alternatives Have Lower Benign prostatic hyperplasia Risk?
OCTREOTIDE vs OCTREOTIDE\OCTREOTIDE
OCTREOTIDE vs ODEVIXIBAT
OCTREOTIDE vs OFATUMUMAB
OCTREOTIDE vs OFLOXACIN
OCTREOTIDE vs OLANZAPINE